These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 19497739)
1. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors. Park H; Bahn YJ; Ryu SE Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739 [TBL] [Abstract][Full Text] [Related]
2. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening. Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978 [TBL] [Abstract][Full Text] [Related]
3. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors. Park H; Li M; Choi J; Cho H; Ham SW Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977 [TBL] [Abstract][Full Text] [Related]
4. Identification of novel inhibitors of extracellular signal-regulated kinase 2 based on the structure-based virtual screening. Park H; Bahn YJ; Jeong DG; Woo EJ; Kwon JS; Ryu SE Bioorg Med Chem Lett; 2008 Oct; 18(20):5372-6. PubMed ID: 18835158 [TBL] [Abstract][Full Text] [Related]
5. Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening. Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ Bioorg Med Chem Lett; 2008 Apr; 18(7):2250-5. PubMed ID: 18358718 [TBL] [Abstract][Full Text] [Related]
6. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties. Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases. Valente S; Bana E; Viry E; Bagrel D; Kirsch G Bioorg Med Chem Lett; 2010 Oct; 20(19):5827-30. PubMed ID: 20800482 [TBL] [Abstract][Full Text] [Related]
8. Nanosecond molecular dynamics simulations of Cdc25B and its complex with a 1,4-naphthoquinone inhibitor: implications for rational inhibitor design. Ko S; Lee W; Lee S; Park H J Mol Graph Model; 2008 Aug; 27(1):13-9. PubMed ID: 18359256 [TBL] [Abstract][Full Text] [Related]
10. Structure-based de novo design of Eya2 phosphatase inhibitors. Park H; Ryu SE; Kim SJ J Mol Graph Model; 2012 Sep; 38():382-8. PubMed ID: 23085179 [TBL] [Abstract][Full Text] [Related]
11. A sugar-modified phosphole gold complex with antiproliferative properties acting as a thioredoxin reductase inhibitor in MCF-7 cells. Viry E; Battaglia E; Deborde V; Müller T; Réau R; Davioud-Charvet E; Bagrel D ChemMedChem; 2008 Nov; 3(11):1667-70. PubMed ID: 18759235 [No Abstract] [Full Text] [Related]
12. Discovery of the inhibitors of tumor necrosis factor alpha with structure-based virtual screening. Choi H; Lee Y; Park H; Oh DS Bioorg Med Chem Lett; 2010 Nov; 20(21):6195-8. PubMed ID: 20850306 [TBL] [Abstract][Full Text] [Related]
13. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening. Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C. Lavergne O; Fernandes AC; Bréhu L; Sidhu A; Brézak MC; Prévost G; Ducommun B; Contour-Galcera MO Bioorg Med Chem Lett; 2006 Jan; 16(1):171-5. PubMed ID: 16216500 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity. Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones. Sohn J; Kiburz B; Li Z; Deng L; Safi A; Pirrung MC; Rudolph J J Med Chem; 2003 Jun; 46(13):2580-8. PubMed ID: 12801222 [TBL] [Abstract][Full Text] [Related]
17. Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors. Montes M; Braud E; Miteva MA; Goddard ML; Mondésert O; Kolb S; Brun MP; Ducommun B; Garbay C; Villoutreix BO J Chem Inf Model; 2008 Jan; 48(1):157-65. PubMed ID: 18154280 [TBL] [Abstract][Full Text] [Related]
18. Structure-based de novo design and biochemical evaluation of novel BRAF kinase inhibitors. Park H; Jeong Y; Hong S Bioorg Med Chem Lett; 2012 Jan; 22(2):1027-30. PubMed ID: 22196123 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitors. Hayakawa M; Kaizawa H; Moritomo H; Koizumi T; Ohishi T; Yamano M; Okada M; Ohta M; Tsukamoto S; Raynaud FI; Workman P; Waterfield MD; Parker P Bioorg Med Chem Lett; 2007 May; 17(9):2438-42. PubMed ID: 17339109 [TBL] [Abstract][Full Text] [Related]
20. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors. Park H; Bhattarai BR; Ham SW; Cho H Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]